Comparative Neuroprotective Effects of Cyclosporin a and NIM811, a Nonimmunosuppressive Cyclosporin a Analog, following Traumatic Brain Injury
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Earlier experiments have shown that cyclosporin A (CsA) and its non-calcineurin inhibitory analog NIM811 attenuate mitochondrial dysfunction after experimental traumatic brain injury (TBI). Presently, we compared the neuroprotective effects of previously determined mitochondrial protective doses of CsA (20 mg/kg intraperitoneally) and NIM811 (10 mg/kg intraperitoneally) when administered at 15 mins postinjury in preventing cytoskeletal (α-spectrin) degradation, neuro-degeneration, and neurological dysfunction after severe (1.0 mm) controlled cortical impact (CCI) TBI in mice. In a first set of experiments, we analyzed calpain-mediated α-spectrin proteolysis at 24 h postinjury. Both NIM811 and CsA significantly attenuated the increased α-spectrin breakdown products observed in vehicle-treated animals ( P < 0.005). In a second set of experiments, treatment of animals with either NIM811 or CsA at 15 mins and again at 24 h postinjury attenuated motor function impairment at 48 h and 7 days ( P < 0.005) and neurodegeneration at 7 days postinjury ( P < 0.0001). Delayed administration of NIM811 out to 12 h was still able to significantly reduce α-spectrin degradation. These results show that the neuroprotective mechanism of CsA involves maintenance of mitochondrial integrity and that calcineurin inhibition plays little or no role because the non-calcineurin inhibitory analog, NIM811, is as effective as CsA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432 · cited 8×
“…plays a critical role in posttraumatic neuronal death (Xiong et al, 1997), and that the formation and opening of the mitochondrial permeability transition pore (mPTP) is one of the core mediators of this process (Ankarcrona et al, 1995; Bernardi, 1996; Crompton, 1999; Sullivan et al, 1999).”
BackgroundInfluentialAnkarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., & Nicotera, P. (1995) · Neuron · doi:10.1016/0896-6273(95)90186-8 · Cited by 1,884 · cited 1×
“…plays a critical role in posttraumatic neuronal death (Xiong et al, 1997), and that the formation and opening of the mitochondrial permeability transition pore (mPTP) is one of the core mediators of this process (Ankarcrona et al, 1995; Bernardi, 1996; Crompton, 1999; Sullivan et al, 1999).”
BackgroundThe Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain Injury
Faden, A. I., Demediuk, P., Panter, S. S., & Vink, R. (1989) · Science · doi:10.1126/science.2567056 · Cited by 1,508 · cited 1×
“…(Ca + 2 ) overload, reactive oxygen species (ROS) generation, activation of cysteine proteases such as calpain and activation of apoptotic cell death cascades (Buki et al, 1999b; Crompton, 1999; Faden et al, 1989; Hall et al, 1994; McIntosh et al, 1996; Okonkwo et al, 1999; Saatman et al, 1996).”
BackgroundSingh, I. N., Sullivan, P. G., Deng, Y., Mbye, L. H., & Hall, E. D. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600297 · Cited by 367
Self-citationSaatman, K. E., Contreras, P. C., Smith, D. H., Raghupathi, R., McDermott, K. L., Fernandez, S. C., Sanderson, K. L., Voddi, M., & McIntosh, T. K. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6629 · Cited by 185 · cited 1×
“This motor test has been shown to correlate with injury severity (Nakamura et al, 1999), and is known to be sensitive to pharmacological manipulation (Saatman et al, 1997).”
BackgroundSelf-citationDENG, Y., THOMPSON, B., GAO, X., & HALL, E. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.023 · Cited by 153 · cited 6×
“The 24 h time point was chosen based on it being the peak of posttraumatic a-spectrin breakdown in the mouse CCI model (Deng et al, 2007 ). post hoc comparison of intergroup differences showed that mean 145 kDa SBDP in ipsilateral cortical tissue isolated from injured vehicle-treated animals was…”
BackgroundMethodInfluentialSelf-citationKupina, N. C., Detloff, M. R., Bobrowski, W. F., Snyder, B. J., & Hall, E. D. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00048-1 · Cited by 111
Self-citation
Cited by
Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets
Ng, S. Y., & Lee, A. Y. W. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00528 · Cited by 852
Loane, D. J., & Faden, A. I. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.005 · Cited by 574
Early management of severe traumatic brain injury
Rosenfeld, J. V., Maas, A. I., Bragge, P., Morganti-Kossmann, M. C., Manley, G. T., & Gruen, R. L. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60864-2 · Cited by 558
Figueira, T. R., Barros, M. H., Camargo, A. A., Castilho, R. F., Ferreira, J. C. B., Kowaltowski, A. J., Sluse, F. E., Souza-Pinto, N. C., & Vercesi, A. E. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4729 · Cited by 419
Diaz-Arrastia, R., Kochanek, P. M., Bergold, P., Kenney, K., Marx, C. E., Grimes, C. J. B., Loh, L. Y., Adam, L. G. E., Oskvig, D., Curley, K. C., et al. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3019 · Cited by 262
Metadata
- Authors
- Mbye, L. H., Singh, I. N., Carrico, K. M., Saatman, K. E., & Hall, E. D.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2008-08-20
- Volume
- 29
- Issue
- 1
- Pages
- 87-97
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2027110425
- Cited by
- 115
- References
- 8
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.